Roivant Sciences Ltd.

NASDAQ:ROIV

12 (USD) • At close September 18, 2024
Bedrijfsnaam Roivant Sciences Ltd.
Symbool ROIV
Munteenheid USD
Prijs 12
Beurswaarde 8,874,264,000
Dividendpercentage 0%
52-weken bereik 8.245 - 13.24
Industrie Biotechnology
Sector Healthcare
CEO Mr. Matthew Gline
Website https://roivant.com

An error occurred while fetching data.

Over Roivant Sciences Ltd.

Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne, myasthenia gravis, warm autoimmune hemolytic anemia, thyroid eye diseases, sarcoidosis,

Vergelijkbare Aandelen

Denali Therapeutics Inc. logo

Denali Therapeutics Inc.

DNLI

30.76 USD

Pacira BioSciences, Inc. logo

Pacira BioSciences, Inc.

PCRX

14.65 USD

Privia Health Group, Inc. logo

Privia Health Group, Inc.

PRVA

19.07 USD

LifeStance Health Group, Inc. logo

LifeStance Health Group, Inc.

LFST

6.74 USD

STAAR Surgical Company logo

STAAR Surgical Company

STAA

31.39 USD

Telesis Bio, Inc. logo

Telesis Bio, Inc.

TBIO

1.36 USD

ACADIA Pharmaceuticals Inc. logo

ACADIA Pharmaceuticals Inc.

ACAD

16.33 USD

Neogen Corporation logo

Neogen Corporation

NEOG

17.24 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)